← Eichor
Condition: Sinonasal Undifferentiated Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Sinonasal Undifferentiated Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Toripalimab With Chemotherapy for Sinus Cancer
Phase 2 · 2 location(s) · Glenn J. Hanna · NCT06940180Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Phase 1/Phase 2 · 2 location(s) · University of Arizona · NCT06814496Pembrolizumab in Locally Advanced Sinonasal Carcinoma
Phase 2 · 1 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT05925491Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06176989
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.